Robert J Adelman - Net Worth and Insider Trading

Robert J Adelman Net Worth

The estimated net worth of Robert J Adelman is at least $4,283 dollars as of 2024-05-24. Robert J Adelman is the Director, 10% Owner of Metacrine Inc and owns about 3,059,123 shares of Metacrine Inc (MTCR) stock worth over $4,283. Details can be seen in Robert J Adelman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert J Adelman has not made any transactions after 2020-09-18 and currently still holds the listed stock(s).

Transaction Summary of Robert J Adelman

To

Robert J Adelman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert J Adelman owns 10 companies in total, including Metacrine Inc (MTCR) , Checkmate Pharmaceuticals Inc (CMPI) , and ALX Oncology Holdings Inc (ALXO) among others .

Click here to see the complete history of Robert J Adelman’s form 4 insider trades.

Insider Ownership Summary of Robert J Adelman

Ticker Comapny Transaction Date Type of Owner
MTCR Metacrine Inc 2020-09-18 director & 10 percent owner
CMPI Checkmate Pharmaceuticals Inc 2020-08-06 10 percent owner
ALXO ALX Oncology Holdings Inc 2020-07-16 10 percent owner & other: See Remarks
2020-07-01 10 percent owner
2019-03-27 director & 10 percent owner
2008-11-14 director & 10 percent owner
2021-04-22 10 percent owner
2022-05-25 10 percent owner
2021-10-20 10 percent owner & other: See Remarks
2023-09-14 10 percent owner

Robert J Adelman Latest Holdings Summary

Robert J Adelman currently owns a total of 1 stock. Robert J Adelman owns 3,059,123 shares of Metacrine Inc (MTCR) as of September 18, 2020, with a value of $4,283.

Latest Holdings of Robert J Adelman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MTCR Metacrine Inc 2020-09-18 3,059,123 0.00 4,283

Holding Weightings of Robert J Adelman


Robert J Adelman Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert J Adelman has made a total of 1 transactions in Metacrine Inc (MTCR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Metacrine Inc is the acquisition of 230,000 shares on September 18, 2020, which cost Robert J Adelman around $3 Million.

Insider Trading History of Robert J Adelman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert J Adelman Trading Performance

GuruFocus tracks the stock performance after each of Robert J Adelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert J Adelman is -12.87%. GuruFocus also compares Robert J Adelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert J Adelman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert J Adelman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert J Adelman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.83
Relative Return to S&P 500(%) 1.88

Robert J Adelman Ownership Network

Ownership Network List of Robert J Adelman

No Data

Ownership Network Relation of Robert J Adelman


Robert J Adelman Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Robert J Adelman is the director & 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

Over the past 18 months, Robert J Adelman made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net sale of 380,605 shares made by Preston Klassen , a net purchase of 271,605 shares made by Braden Michael Leonard , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 271,605 shares were bought by its insiders, resulting in a net sale of 216,054 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Metacrine Inc Insider Transactions

No Available Data

Robert J Adelman Mailing Address

Above is the net worth, insider trading, and ownership report for Robert J Adelman. You might contact Robert J Adelman via mailing address: 1700 Owens Street, Suite 595, San Francisco Ca 94158.

Discussions on Robert J Adelman

No discussions yet.